Paraskevi Giannakakou

Cornell University

Full Professor(heuristic)

Prostate Cancer Treatment and Research · Pulmonary and Respiratory Medicine

Compare more Pulmonary and Respiratory Medicine professors.

h-index60
i10-index100
Publications369
Citations14,634

Grants

11 total · 1 active

NIH #R01CA266704

Enhancing the Efficacy of Docetaxel in Prostate Cancer

Active
Amount
$600K–$700K
Period
2022-07-13 → 2027-06-30
PIs
2

Awarded at BETH ISRAEL DEACONESS MEDICAL CENTER

NIH #T32CA203702

Molecular and Translational Oncology Research

Amount
$200K–$300K
Period
2017-07-01 → 2023-06-30
PIs
2

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

NIH #R01CA228512

A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore.

Amount
$500K–$600K
Period
2018-04-19 → 2023-03-31
PIs
3

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

11 total · 1 active

NIH #R01CA266704

Enhancing the Efficacy of Docetaxel in Prostate Cancer

Active
Amount
$600K–$700K
Period
2022-07-13 → 2027-06-30
PIs
2

Awarded at BETH ISRAEL DEACONESS MEDICAL CENTER

NIH #T32CA203702

Molecular and Translational Oncology Research

Amount
$200K–$300K
Period
2017-07-01 → 2023-06-30
PIs
2

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

NIH #R01CA228512

A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore.

Amount
$500K–$600K
Period
2018-04-19 → 2023-03-31
PIs
3

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

NIH #R21CA216800

Biomarkers of taxane chemotherapy response/resistance in prostate cancer

Amount
$200K–$300K
Period
2018-04-01 → 2020-03-31
PIs
1

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

NIH #R01CA179100

Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resis

Amount
$400K–$500K
Period
2014-04-11 → 2020-02-29
PIs
2

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

NIH #R01CA177165

Microtubule-Regulated RNA Translation: Implications for Taxane Chemotherapy

Amount
$400K–$500K
Period
2014-05-01 → 2019-04-30
PIs
1

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

NIH #R01CA137020

Microtubule dependent AR signaling predicts taxane sensitivity

Amount
$300K–$400K
Period
2009-08-01 → 2014-05-31
PIs
1

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

NIH #P01CA116676

Targeting Microtubules and HDAC6 in NSCLC

Amount
$400K–$500K
Period
— → 2014-05-31
PIs
1

Awarded at EMORY UNIVERSITY

NIH #R01CA114335

Microtubule-targeting and regulation of HIF-1

Amount
$200K–$300K
Period
2005-04-01 → 2010-03-31
PIs
1

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

NIH #R01CA100202

Antitubulin drugs: Mechanisms of action and resistance

Amount
$200K–$300K
Period
2003-04-15 → 2008-03-31
PIs
1

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

NIH #P50CA211024

Developmental Research Program (DRP)

Amount
<$100K
Period
— → —
PIs
1

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

Recent Public Signals

  1. New paper: Abstract LB346: A first-in-class TAU-1-directed androgen receptor (AR) and AR-V7 degrader recruits DDB1-CUL4-RBX1 E3 ligase to eliminate AR signaling in lethal prostate cancer (Cancer Research)2026-04-17
  2. New preprint: TMPO promotes cellular dissemination and metastasis in circulating tumor cells2025-12-27
  3. New NIH award: Enhancing the Efficacy of Docetaxel in Prostate Cancer2022-07-13

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0001-7378-262X

Professor Insights

Career Trajectory